Breaking barriers between clinicians and patients

RetinAI Medical is a Swiss company that supports eye care professionals and patients throughout the medical examination process using Artificial Intelligence (AI). Our vision is to foster the transition from reactive medicine to preventive medicine for high-impact diseases such as Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR) and Glaucoma. 

Our solutions rely on the latest advances in medical image analysis, ophthalmology and machine learning. We have a unique team of scientists working to fully realize the capabilities of AI, and to integrate this technology into the next generation of medical devices.

Screenshot 2017-07-24 22.37.19.png

optical coherence tomography (oct)

In depth analysis of volumetric OCT is a requirement to detect and monitor multiple eye diseases, such as early AMD or Diabetic Retinopathy. Early detection is key for maximizing eyesight preservation. 

Screenshot 2017-07-24 22.41.09.png

fundus image photography

Fundus imaging is the modality of reference to detect pathologies in the retina (e.g. AMD, DR and Glaucoma). Our technology facilitates integration of Fundus Image processing capabilities into current existing mobile devices.

Lima01.jpg

oct angiography

Optical Coherence Tomography Angiography has the potential for imaging retinal vascular diseases. It provides volumetric information with the clinical capability of localizing and delineating pathologies and compute the retinal blood flow (e.g. for Diabetic Retinopathy).



SUPPORT:

Collaborators: